SwePub
Sök i LIBRIS databas

  Extended search

onr:"swepub:oai:DiVA.org:uu-17428"
 

Search: onr:"swepub:oai:DiVA.org:uu-17428" > Prognostic role of ...

  • 1 of 1
  • Previous record
  • Next record
  •    To hitlist
  • Heinonen, Mira (author)

Prognostic role of HuR in hereditary breast cancer

  • Article/chapterEnglish2007

Publisher, publication year, extent ...

  • 2007
  • printrdacarrier

Numbers

  • LIBRIS-ID:oai:DiVA.org:uu-17428
  • https://urn.kb.se/resolve?urn=urn:nbn:se:uu:diva-17428URI
  • https://doi.org/10.1158/1078-0432.CCR-07-1432DOI

Supplementary language notes

  • Language:English
  • Summary in:English

Part of subdatabase

Classification

  • Subject category:ref swepub-contenttype
  • Subject category:art swepub-publicationtype

Notes

  • Purpose: HuR is an mRNA-binding protein that enhances the stability of certain transcripts and can regulate their translation. Elevated cytoplasmic expression of HuR protein has been linked to carcinogenesis and is associated with reduced survival in breast, ovarian, and gastric adenocarcinomas. Experimental Design: Here, we have explored the relevance of HuR in familial breast cancer. Tumor samples were collected from patients with identified BRCA1 (n = 51) or BRCA2 (n = 47) mutations or familial non-BRCA1/2 cases (n = 525), and analyzed by immunohistochemistry. Results: Among familial non-BRCAI/2 breast cancer patients, cytoplasmic HuR protein expression was present in 39.4% of the cases and was associated with estrogen receptor negativity, progesterone receptor negativity, p53 positivity, high tumor grade, and ductal type of the tumor. In multivariate analysis, cytoplasmic HuR expression was an independent marker of reduced survival in the non-BRCAI/2 group along with tumor size >2 cm, lymph node metastasis, and high histologic grade. In patients with BRCA1 or BRCA2 mutations, cytoplasmic HuR expression was more frequent (62.7% for BRCA1 and 61.7% for BRCA2) than in the non-BRCA1/ 2 group, but in BRCA -mutated subgroups cytoplasmic HuR expression did not associate with survival. Conclusions: Our results show that HuR is an important prognostic factor in familial breast cancer patients and may contribute to carcinogenesis in this disease.

Subject headings and genre

  • Adult
  • Aged
  • Aged; 80 and over
  • Antigens; Surface/*biosynthesis/genetics
  • Breast Neoplasms/*genetics/*metabolism/pathology
  • Female
  • Genes; BRCA1
  • Genes; BRCA2
  • Humans
  • Kaplan-Meiers Estimate
  • Middle Aged
  • Prognosis
  • RNA-Binding Proteins/*biosynthesis/genetics
  • MEDICINE
  • MEDICIN

Added entries (persons, corporate bodies, meetings, titles ...)

  • Fagerholm, Rainer (author)
  • Aaltonen, Kirsimari (author)
  • Kilpivaara, Outi (author)
  • Aittomäki, Kristiina (author)
  • Blomqvist, CarlUppsala universitet,Institutionen för onkologi, radiologi och klinisk immunologi,Bröstgruppen(Swepub:uu)carlblom (author)
  • Heikkilä, Päivi (author)
  • Haglund, Caj (author)
  • Nevanlinna, Heli (author)
  • Ristimäki, Ari (author)
  • Uppsala universitetInstitutionen för onkologi, radiologi och klinisk immunologi (creator_code:org_t)

Related titles

  • In:Clinical Cancer Research13:23, s. 6959-69631078-04321557-3265

Internet link

Find in a library

To the university's database

  • 1 of 1
  • Previous record
  • Next record
  •    To hitlist

Kungliga biblioteket hanterar dina personuppgifter i enlighet med EU:s dataskyddsförordning (2018), GDPR. Läs mer om hur det funkar här.
Så här hanterar KB dina uppgifter vid användning av denna tjänst.

 
pil uppåt Close

Copy and save the link in order to return to this view